Judgment of the Court (First Chamber) of 6 December 2012.
AstraZeneca AB and AstraZeneca plc v European Commission.
Appeals - Competition - Abuse of dominant position - Market in anti-ulcer medicines - Abuse of procedures relating to supplementary protection certificates for medicinal products and of marketing authorisation procedures for medicinal products - Misleading representations - Deregistration of marketing authorisations - Obstacles to the marketing of generic medicinal products and to parallel imports.
Case C-457/10 P.
Reports of Cases
Not yet published (General Report - Section 'Information on unpublished decisions')
Links to the texts